CBD for sleep — what the evidence shows
Short answer
Emerging evidenceCBD evidence for sleep is early and inconsistent. High doses (150–300 mg) may improve sleep in anxious adults; lower doses common in retail products show little effect. The biggest practical problem is quality control: actual CBD content varies wildly between products.
Key points
- Mechanism uncertain — likely indirect, via reduced anxiety, modulation of cortisol, and endocannabinoid system effects.
- Trials at 25–75 mg (typical retail doses) show minimal sleep effect. Trials at 150–300 mg show some benefit.
- Highly variable product quality — many products contain less CBD than labelled, some contain detectable THC.
- Anxiolytic effect is more reliable than direct sedative effect.
- Worth a cautious trial for anxiety-related sleep difficulty. Not first-line for primary insomnia.
Verdict
CBD for sleep is one of the most-marketed and least-evidenced supplement categories. Trials are short, samples small, doses inconsistent, and product quality genuinely problematic. If you want to try it, do so cautiously, at adequate doses, with a tested-quality product, and don't expect dramatic results.
The mechanism question
CBD (cannabidiol) is a non-psychoactive cannabinoid that interacts with the body's endocannabinoid system. It also affects serotonin receptors, GABA signalling, and several anxiety-related pathways. The exact mechanism for any sleep effect isn't pinned down.
The most likely route is indirect: CBD reduces anxiety in many users, which reduces the sleep-onset arousal that prevents sleep. It's probably more anxiolytic than sedative.
What trials show
Best current evidence base:
- Shannon et al (2019): retrospective study of 72 adults with anxiety/sleep complaints, ~25 mg/day. ~67% reported improved sleep at one month. Open-label, no control — suggestive only.
- Carlini & Cunha (1981, classic): 160 mg of CBD before bed in adults with insomnia. Improved subjective sleep quality.
- Several small RCTs in 2020–2023 at doses of 150–300 mg show modest improvements in sleep onset and quality. Effects at lower doses (25–75 mg) are usually within placebo range.
The pattern: at modest-to-high doses, in stressed or anxious populations, CBD probably helps a bit. In healthy good sleepers at the doses most people use, effect is small.
The dosing problem
Most commercial CBD gummies and oils contain 10–25 mg per serving. The trials showing sleep benefit typically use 150–300 mg. Retail doses are likely too low to produce the effects studies report.
Doubling or tripling a serving size to reach trial doses is expensive and may not be safe long-term — CBD has documented liver enzyme effects (CYP450 inhibition) at high doses.
The quality control problem
Multiple analyses of commercial CBD products have found:
- Wide variability between label and actual CBD content (sometimes 50%+ off).
- Detectable THC in many products labelled THC-free.
- Synthetic cannabinoid contamination in some products.
- Inconsistent batches within the same brand.
Buy from brands with public third-party testing (Certificate of Analysis available per batch). Avoid the cheapest products. Even with these precautions, variability remains higher than for most other supplement categories.
Side effects and interactions
Generally well-tolerated at standard doses. Reported side effects: dry mouth, mild GI upset, drowsiness (sometimes unwanted next-day), changes in appetite.
Major caveat: CBD inhibits CYP450 enzymes, affecting metabolism of many medications. Notable interactions:
- Blood thinners (warfarin).
- Anti-epileptic drugs.
- Several antidepressants.
- Some immunosuppressants.
Check with a pharmacist if you take any prescription medication.
Practical guidance
- If you want to try CBD for sleep, aim for at least 50 mg as a starting dose.
- Buy from a brand with batch-specific Certificates of Analysis.
- Trial for 2–4 weeks; if no clear effect, stop.
- Don't take alongside other sedatives or sleep medications.
- Don't expect transformative results. The data doesn't support that expectation.